Bikfalvi A - Search Results

1

Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A. Bello L, et al. Among authors: bikfalvi a. Cancer Treat Res. 2004;117:263-84. doi: 10.1007/978-1-4419-8871-3_16. Cancer Treat Res. 2004. PMID: 15015565 Review.

2

Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.

Auguste P, Gürsel DB, Lemière S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfalvi A. Auguste P, et al. Among authors: bikfalvi a. Cancer Res. 2001 Feb 15;61(4):1717-26. Cancer Res. 2001. PMID: 11245488

3

Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.

Bello L, Carrabba G, Giussani C, Lucini V, Cerutti F, Scaglione F, Landré J, Pluderi M, Tomei G, Villani R, Carroll RS, Black PM, Bikfalvi A. Bello L, et al. Among authors: bikfalvi a. Cancer Res. 2001 Oct 15;61(20):7501-6. Cancer Res. 2001. PMID: 11606386

4

Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.

Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM. Bello L, et al. Among authors: bikfalvi a. Cancer Res. 2001 Dec 15;61(24):8730-6. Cancer Res. 2001. PMID: 11751392

5

Suppression of malignant glioma recurrence in a newly developed animal model by endogenous inhibitors.

Bello L, Giussani C, Carrabba G, Pluderi M, Lucini V, Pannacci M, Caronzolo D, Tomei G, Villani R, Scaglione F, Carroll RS, Bikfalvi A. Bello L, et al. Among authors: bikfalvi a. Clin Cancer Res. 2002 Nov;8(11):3539-48. Clin Cancer Res. 2002. PMID: 12429645

6

Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.

Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A. Hagedorn M, et al. Among authors: bikfalvi a. Cancer Res. 2002 Dec 1;62(23):6884-90. Cancer Res. 2002. PMID: 12460903

7

IS20I, a specific alphavbeta3 integrin inhibitor, reduces glioma growth in vivo.

Bello L, Lucini V, Giussani C, Carrabba G, Pluderi M, Scaglione F, Tomei G, Villani R, Black PM, Bikfalvi A, Carroll RS. Bello L, et al. Among authors: bikfalvi a. Neurosurgery. 2003 Jan;52(1):177-85; discussion 185-6. doi: 10.1097/00006123-200301000-00023. Neurosurgery. 2003. PMID: 12493116

8

Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo.

Giussani C, Carrabba G, Pluderi M, Lucini V, Pannacci M, Caronzolo D, Costa F, Minotti M, Tomei G, Villani R, Carroll RS, Bikfalvi A, Bello L. Giussani C, et al. Among authors: bikfalvi a. Cancer Res. 2003 May 15;63(10):2499-505. Cancer Res. 2003. PMID: 12750272

9

Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.

Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, Costa F, Caronzolo D, Balke M, Canron X, Convert O, Laïn G, Gionnet K, Goncalvès M, Bayle M, Bello L, Chassaing G, Deleris G, Bikfalvi A. Zilberberg L, et al. Among authors: bikfalvi a. J Biol Chem. 2003 Sep 12;278(37):35564-73. doi: 10.1074/jbc.M304435200. Epub 2003 Jul 1. J Biol Chem. 2003. PMID: 12837752 Free article.

10

Long-term inhibition of glioma growth by systemic administration of human PEX.

Pluderi M, Lucini V, Caronzolo D, Pannacci M, Costa F, Carrabba G, Giussani C, Grosso S, Colleoni F, Scaglione F, Villani R, Bikfalvi A, Bello L. Pluderi M, et al. Among authors: bikfalvi a. J Neurosurg Sci. 2003 Jun;47(2):69-78. J Neurosurg Sci. 2003. PMID: 14618134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page